Lakefront Biotherapeutics (LKFT) Total Debt (2019 - 2025)
Lakefront Biotherapeutics (LKFT) posted quarterly Total Debt of $5820.2 for Q4 2025, up 8.93% year-over-year from $5343.0 in Q4 2024, and up 8.93% quarter-over-quarter from $5343.0 in Q4 2024.
Lakefront Biotherapeutics (LKFT) Total Debt (2019 - 2025) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Total Debt for 6 consecutive years, with $5820.2 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Debt rose 8.93% year-over-year to $5820.2; the TTM figure through Dec 2025 stood at $5820.2 (up 8.93% YoY), while the FY2025 annual figure was $5820.2, up 8.93% from the prior year.
- Total Debt advanced to $5820.2 in Q4 2025 per LKFT's latest filing, from $5343.0 in the prior quarter.
- Across five years, Total Debt topped out at $436589.4 in Q1 2022 and bottomed at $5343.0 in Q4 2024.
- Historically, Total Debt has averaged $217151.6 across 4 years, with a median of $233370.1 in 2021.
- Annual changes were most pronounced in 2021 — Total Debt plunged 98.66% — and 2025, when it gained 8.93%.
- Lakefront Biotherapeutics' Total Debt stood at $233370.1 in 2021, then surged by 87.08% to $436589.4 in 2022, then slumped by 98.78% to $5343.0 in 2024, then climbed by 8.93% to $5820.2 in 2025.
- Business Quant data shows LKFT's Total Debt at $5820.2 in Q4 2025, $5343.0 in Q4 2024, and $436589.4 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Lakefront Biotherapeutics | 1.81 Bn | -1.68 Bn | 1.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,820.22 |
| Dec 31, 2024 | 5,342.98 |
| Mar 31, 2022 | 436,589.37 |
| Dec 31, 2021 | 233,370.07 |
| Jun 30, 2021 | 404,635.20 |
| Dec 31, 2020 | 3.77 Mn |
| Jun 30, 2020 | 30.09 Mn |
| Mar 31, 2020 | 29.50 Mn |
| Dec 31, 2019 | 6.86 Mn |